SIO CAPITAL MANAGEMENT LLC
Q3 2026 Form 13-F
NEW YORK, NEW YORK
CIK 0001482416
· CRD 165989
· SEC-registered investment adviser
$528.5M Reported Value Total
SIO CAPITAL MANAGEMENT, LLC reports 6 total accounts under management (AUM). There are 6 discretionary accounts valued at $1,293,066,687, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
6 funds
· $864.7M gross asset value
Hedge Fund: $864.7M
Source: Form ADV filed 2026-03-18
Reported value
$528.5M
Quarter over quarter
-6.5%
Holdings
51
Top-10 concentration
47.3%
Key People
Form ADV owners & control persons
Michael Bernard Castor
MANAGING MEMBER
Judah Zvi Drillick
CHIEF EXECUTIVE OFFICER
Jin Woo Lee
CHIEF COMPLIANCE OFFICER
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q3 2026 13F record
Q3 2026 13F filing summary
| Period of report | September 30, 2026 |
|---|---|
| Filed | November 16, 2026 |
| Form | 13F-HR |
| Reported value | $528.5M |
| Positions | 51 |
| Change in reported value | -12.5% |
| New positions | 12 |
| Exited positions | 18 |
| Position turnover | 43.5% |
| Top-10 concentration | 47.3% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 16, 2026
|
51 | $528.5M |
|
Q2 2026 13F
Filed Aug 14, 2026
|
57 | $604.3M |
|
Q1 2026 13F
Filed May 14, 2026
|
73 | $697.3M |
|
Q4 2025 13F
Filed Feb 17, 2026
|
65 | $635.7M |
|
Q3 2025 13F
Filed Nov 13, 2025
|
51 | $395.2M |
|
Q2 2025 13F
Filed Aug 13, 2025
|
49 | $261.8M |
|
Q1 2025 13F
Filed May 15, 2025
|
53 | $335.8M |
|
Q4 2024 13F
Filed Feb 14, 2025
|
51 | $355.4M |
|
Q3 2024 13F
Filed Nov 14, 2024
|
38 | $252.2M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
46 | $369.5M |
|
Q1 2024 13F
Filed May 15, 2024
|
48 | $335.8M |
|
Q4 2023 13F
Filed Feb 13, 2024
|
39 | $439.2M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
52 | $323.1M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
41 | $393.2M |
|
Q1 2023 13F
Filed May 12, 2023
|
44 | $202.3M |
|
Q4 2022 13F
Filed Feb 13, 2023
|
41 | $270.4M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
43 | $314.7M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
59 | $266.2M |
|
Q1 2022 13F
Filed May 16, 2022
|
61 | $302.3M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
67 | $331.7M |
28 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q3 2026
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | AVR ANTERIS TECHNOLOGIES GLOBAL | $40.2M | 7.61% |
| 2 | GMED GLOBUS MED INC | $35.7M | 6.75% |
| 3 | GSK GSK PLC | $32.3M | 6.12% |
| 4 | ICLR ICON PUB LTD CO | $24.0M | 4.53% |
| 5 | SENS SENSEONICS HLDGS INC | $23.3M | 4.41% |
| 6 | MRK P MERCK & CO INC | $21.8M | 4.12% |
| 7 | MRK MERCK & CO INC | $21.1M | 4.0% |
| 8 | IDYA IDEAYA BIOSCIENCES INC | $19.2M | 3.64% |
| 9 | PFE P PFIZER INC | $17.1M | 3.24% |
| 10 | SLS P SELLAS LIFE SCIENCES GROUP I | $15.1M | 2.87% |
| 11 | SNY SANOFI SA | $14.7M | 2.78% |
| 12 | ALLO ALLOGENE THERAPEUTICS INC | $14.6M | 2.76% |
| 13 | MMS MAXIMUS INC | $14.3M | 2.7% |
| 14 | RLMD RELMADA THERAPEUTICS INC | $13.7M | 2.59% |
| 15 | VTRS VIATRIS INC | $13.4M | 2.53% |
| 16 | AVAH AVEANNA HEALTHCARE HLDGS INC | $12.6M | 2.38% |
| 17 | REPL REPLIMUNE GROUP INC | $11.5M | 2.17% |
| 18 | TNGX TANGO THERAPEUTICS INC | $10.7M | 2.02% |
| 19 | ANIP ANI PHARMACEUTICALS INC | $10.6M | 2.01% |
| 20 | BMRN BIOMARIN PHARMACEUTICAL INC | $10.5M | 1.98% |
Values as reported on the Q3 2026 Form 13F. Every position is in the holdings table below.